SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-13-003102
Filing Date
2013-06-13
Accepted
2013-06-12 20:21:21
Documents
11

Document Format Files

Seq Description Document Type Size
1 AMENDED REGISTRATION STATEMENT fs12013a3_soligenix.htm S-1/A 1916790
2 PLACE AGENCY AGREEMENT fs12013a3ex1i_soligenix.htm EX-1.1 211562
3 LEGAL OPINION fs12013a3ex5i_soligenix.htm EX-5.1 18913
4 CONSENT OF EISNER AMPER LLP fs12013a3ex21i_soligenix.htm EX-21.1 10896
5 CONSENT OF DUANE MORRIS LLP (CONTAINED IN THE OPINION FILED AS EXHIBIT 5.1 HERET fs12013a3ex23i_soligenix.htm EX-23.1 2713
  Complete submission text file 0001213900-13-003102.txt   8245518

Data Files

Seq Description Document Type Size
6 XBRL sngx-20130331.xml EX-101.INS 1235928
7 XBRL sngx-20130331.xsd EX-101.SCH 46191
8 XBRL sngx-20130331_cal.xml EX-101.CAL 40710
9 XBRL sngx-20130331_def.xml EX-101.DEF 153025
10 XBRL sngx-20130331_lab.xml EX-101.LAB 374542
11 XBRL sngx-20130331_pre.xml EX-101.PRE 292836
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-184762 | Film No.: 13909961
SIC: 2834 Pharmaceutical Preparations